Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers

References

• MA House of Representatives Bill No.3656. An Act requiring practitioners to be held responsible for patient opioid addiction. 1 22, 2019 Available from: https://malegislature.gov/Bills/191/HD3469 Accessed 101, 2019.
   Google Scholar
• Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41–51. doi:10.4137/sart.s234524357929
   PubMedGoogle Scholar
• O’Brien J. A review and evaluation of Indiana’s INSPECT system and governing legislation: maximizing potential impact on public health. Indiana Health Law Rev. 2012;10(2):701–739.
   Google Scholar
• Ballantyne JC, Fleisher LA. Ethical issues in opioid prescribing for chronic pain. Pain. 2010;148(3):365–367. doi:10.1016/j.pain.2009.10.02019906487
   PubMed Web of Science ®Google Scholar
• Hoffmann DE, Tarzian AJ. Achieving the right balance in oversight of physician opioid prescribing for pain: the role of state medical boards. J Law Med Ethics. 2003;31(1):21–40. doi:10.1111/j.1748-720X.2003.tb00057.x
   Web of Science ®Google Scholar
• Schmidt C. Experts worry about chilling effect of federal regulations on treating pain. J Natl Cancer Inst. 2005;97(8):554–555. doi:10.1093/jnci/97.8.55415840873
   PubMedGoogle Scholar
• Goldenbaum DM, Christopher M, Gallagher RM, et al. Physicians charged with opioid analgesic-prescribing offenses. Pain Med. 2008;9(6):737–747. doi:10.1111/j.1526-4637.2008.00482.x18657218
   PubMed Web of Science ®Google Scholar
• Brown MA, Lobb JQ, Novak-Tibbitt R, Rowe WJ. American Pain Foundation position statement on access to pain care. J Pain Palliat Care Pharmacother. 2011;25(2):165–170. doi:10.3109/15360288.2010.52560221657864
   PubMedGoogle Scholar
• Green TC, Bowman SE, Ray M, Zaller N, Heimer R, Case P. Collaboration or coercion? Partnering to divert prescription opioid medications. J Urban Health. 2013;90(4):758–767. doi:10.1007/s11524-012-9784-523371052
   PubMed Web of Science ®Google Scholar
• Garcia AM. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. J Law Med Ethics. 2013;41(Suppl 1):42–45. doi:10.1111/jlme.12037
   Web of Science ®Google Scholar
• Voas RB, DuPont RL, Shea CL, Talpins SK. Prescription drugs, drugged driving and per se laws. Inj Prev. 2013;19(3):218–221. doi:10.1136/injuryprev-2012-04049823024170
   PubMed Web of Science ®Google Scholar
• Katzman JG, Comerci GD, Landen M, et al. Rules and values: a coordinated regulatory and educational approach to the public health crises of chronic pain and addiction. Am J Public Health. 2014;104(8):1356–1362. doi:10.2105/AJPH.2014.30188124922121
   PubMed Web of Science ®Google Scholar
• Ruan X, Luo JJ, Kaye AD. Opioid dependence and pregnancy: minimizing stress on the fetal brain. Am J Obstet Gynecol. 2017;216(4):430. doi:10.1016/j.ajog.2016.11.104027894615
   PubMed Web of Science ®Google Scholar
• Huntoon LR. The perils of opioid prescribing. Am J Physic Surg. 2017;22(4):98–100.
   Google Scholar
• Wee Jun Yan I, Lim Tian Ying B, Brennan F. Public policy: an analgesia for opioid diversion. J Pain Palliat Care Pharmacother. 2018;32(2–3):178–191. doi:10.1080/15360288.2018.154678830676178
   PubMed Web of Science ®Google Scholar
• Gilson AM, Rich BA. Legal and ethical issues in pain management In: Benzon HT, Raja SN, Fishman SM, Liu SS, Cohen SP, editors. Essentials of Pain Medicine. 4th Ed ed. Philadelphia, PA: Elsevier; 2018:395–404.
   Google Scholar
• Schatman ME, Vasciannie A, Kulich RJ. Opioid moderatism and the imperative of rapprochement in pain medicine. J Pain Res. 2019;12:849–857. doi:10.2147/JPR.S198849
   Web of Science ®Google Scholar
• Huang CJ. On being the “right” kind of chronic pain patient. Narrat Inq Bioeth. 2018;8(3):239–245. doi:10.1353/nib.2018.007330595591
   PubMedGoogle Scholar
• Meghani SH, Vapiwala N. Bridging the critical divide in pain management guidelines From the CDC, NCCN, and ASCO for cancer survivors. JAMA Oncol. 2018;4(10):1323–1324. doi:10.1001/jamaoncol.2018.157429852051
   PubMed Web of Science ®Google Scholar
• Schatman ME. A glimmer of hope in American pain medicine? J Pain Res. 2016;9:509–513. doi:10.2147/JPR.S11561927471407
   PubMed Web of Science ®Google Scholar
• Osborne JH. The chilling effect of the CDC guidelines for chronic pain. IC Optimist. 2017;41(4):5–11.
   Google Scholar
• Hartung DM, Kim H, Ahmed SM, et al. Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes. Subst Abus. 2018;39(2):239–246. doi:10.1080/08897077.2017.138979829016245
   PubMed Web of Science ®Google Scholar
• Bohnert ASB, Guy GP Jr, Losby JL. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 opioid guideline. Ann Intern Med. 2018;169(6):367–375. doi:10.7326/M18-124330167651
   PubMed Web of Science ®Google Scholar
• García MC, Heilig CM, Lee SH, et al. Opioid prescribing rates in nonmetropolitan and metropolitan counties among primary care providers using an electronic health record system - United States, 2014-2017. MMWR Morb Mortal Wkly Rep. 2019;68(2):25–30. doi:10.15585/mmwr.mm6802a130653483
   PubMed Web of Science ®Google Scholar
• Juurlink DN. Critiquing the CDC Opioid Guideline: some light from the heat. Clin Pharmacol Ther. 2018;103(6):966–968. doi:10.1002/cpt.v103.629603206
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Murinova N, Krashin DL. Opioid guidelines are a necessary response to the opioid crisis. Clin Pharmacol Ther. 2018;103(6):946–949. doi:10.1002/cpt.v103.629603187
   PubMed Web of Science ®Google Scholar
• Tyndale RF, Sellers EM. Opioids: the painful public health reality. Clin Pharmacol Ther. 2018;103(6):924–935. doi:10.1002/cpt.v103.629878319
   PubMed Web of Science ®Google Scholar
• Kertesz SG. Turning the tide or riptide? The changing opioid epidemic. Subst Abus. 2017;38(1):3–8. doi:10.1080/08897077.2016.126107027858590
   PubMed Web of Science ®Google Scholar
• Gordon AL, Connolly SL. Treating pain in an established patient: sifting through the guidelines. R I Med J (2013). 2017;100(10):41–44.
   Google Scholar
• Arnstein P, Herr K. Shifting focus: from the opioid crisis to quality pain management. J Gerontol Nurs. 2019;45(6):3–5. doi:10.3928/00989134-20190509-01
   Web of Science ®Google Scholar
• Kertesz SG, Gordon AJ. Strict limits on opioid prescribing risk the ‘inhumane treatment’ of pain patients. STAT. 2017 Available from: https://www.statnews.com/2017/02/24/opioids-prescribing-limits-pain-patients/ Accessed October 8, 2019.
   Google Scholar
• Rose ME. Are prescription opioids driving the opioid crisis? Assumptions vs facts. Pain Med. 2018;19(4):793–807. doi:10.1093/pm/pnx04828402482
   PubMed Web of Science ®Google Scholar
• Wegrzyn EL, Chaghtai AM, Argoff CE, Fudin J. The CDC opioid guideline: proponent interpretation has led to m misinformation. Clin Pharmacol Ther. 2018;103(6):950–953. doi:10.1002/cpt.106229608033
   PubMed Web of Science ®Google Scholar
• Kroenke K, Alford DP, Argoff C, et al. Challenges with implementing the Centers for Disease Control and Prevention Opioid Guideline: a consensus panel report. Pain Med. 2019;20(4):724–735. doi:10.1093/pm/pny30730690556
   PubMed Web of Science ®Google Scholar
• Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019;40(1):4–6. doi:10.1080/08897077.2019.161383031100051
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285–2287. doi:10.1056/NEJMp190419031018066
   PubMed Web of Science ®Google Scholar
• Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking. Subst Abus. 2017;38(3):237–238. doi:10.1080/08897077.2017.134519428632485
   PubMed Web of Science ®Google Scholar
• Rhode Island Department of Health. 216-RICR-20-20-4: rules and regulations for pain management, opioid use, and the registration of distributors of controlled substances in Rhode Island. Available from: https://risos-apa-production-public.s3.amazonaws.com/DOH/REG_10819_20190815135427.pdf Accessed 1010, 2019.
   Google Scholar
• Davis CS, Lieberman A, Hernandez-Delgado H, Suba C. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review. Drug Alcohol Depend. 2019;194:166–172. doi:10.1016/j.drugalcdep.2018.09.02230445274
   PubMed Web of Science ®Google Scholar
• Office of the Governor Doug Ducey. Arizona opioid epidemic act; 2018 Available from: https://azgovernor.gov/sites/default/files/opioidepidemicactweb_0.pdf Accessed 1011, 2019.
   Google Scholar
• Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821–826. doi:10.1001/jamapsychiatry.2014.36624871348
   PubMed Web of Science ®Google Scholar
• Bohnert ASB, Guy GP Jr., Losby JL. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 opioid guideline. Ann Intern Med. 2018;169(6):367–375. doi:10.7326/M18-124330167651
   PubMed Web of Science ®Google Scholar
• Buchmueller TC, Carey C. The effect of prescription drug monitoring programs on opioid utilization in Medicare. Am Econ J Appl Econ. 2018;10:77–112.
   Google Scholar
• Jannetto PJ, Bratanow NC, Clark WA, et al. Executive summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline—using clinical laboratory tests to monitor drug therapy in pain management patients. J Appl Lab Med. 2018;2(4):489–526. doi:10.1373/jalm.2017.023341
   PubMedGoogle Scholar
• United States Food and Drug Administration. FDA analysis of long-term trends in prescription opioid analgesic products: quantity, sales, and price trends; 3 1, 2018 Available from: file:///C:/Users/headd/Downloads/AnalgesicOpioidsQuantitySalesPriceWhitePaperFinal3-1-18Corrected.pdf Accessed 1015, 2019.
   Google Scholar
• Schatman ME, Ziegler SJ. Pain management, prescription opioid mortality, and the CDC: is the devil in the data? J Pain Res. 2017;10:2489–2495. doi:10.2147/JPR.S15332229118585
   PubMed Web of Science ®Google Scholar
• Schnoll SH. Misconceptions and realities of the prescription opioid epidemic. Clin Pharmacol Ther. 2018;103(6):963–965.29464692
   PubMed Web of Science ®Google Scholar
• Oliver JE, Carlson C. Misperceptions about the ‘opioid epidemic:’ Exploring the facts. Pain Manag Nurs. [Epub ahead of print] 2019;S1524-9042(19)30072–4. doi:10.1016/j.pmn.2019.05.004.
   Web of Science ®Google Scholar
• Cicero TJ. Is a reduction in access to prescription opioids the cure for the current opioid crisis? Am J Public Health. 2018;108(10):1322–1323. doi:10.2105/AJPH.2018.30464830207773
   PubMed Web of Science ®Google Scholar
• Singer JA, Sullum JZ, Schatman ME. Today’s nonmedical opioid users are not yesterday’s patients: implications of data indicating stable rates of nonmedical and pain reliever use disorder. J Pain Res. 2019;12:617–620. doi:10.2147/JPR.S19975030799947
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Kasper ZA, Ellis MS. Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications. Addict Behav. 2018;87:267–271. doi:10.1016/j.addbeh.2018.05.03030006021
   PubMed Web of Science ®Google Scholar
• Poitras G. The prescription opioid epidemic: an update. Medicoleg Bioeth. 2018;8:21–32. doi:10.2147/MB.S170220
   Google Scholar
• Wood E, Simel DL, Klimas J. Pain management with opioids in 2019–2020. JAMA. [Epub ahead of print] 2019;1–3. doi:10.1001/jama.2019.15802.
   Web of Science ®Google Scholar
• Antoniou T, Ala-Leppilampi K, Shearer D, Parsons JA, Tadrous M, Gomes T. “Like being put on an ice floe and shoved away”: a qualitative study of the impacts of opioid-related policy changes on people who take opioids. Int J Drug Policy. 2019;66:15–22.30685650
   PubMed Web of Science ®Google Scholar
• Nevada Assembly Committee on Health and Human Services. Assembly Bill No. 474, 79th Session, 2017. Available from: https://nvdoctors.org/wp-content/uploads/AB474_Bill-FINAL.pdf Accessed 1011, 2019.
   Google Scholar
• Dickinson BD, Head CA, Gitlow S, Osbahr AJ 3rd. Maldynia: pathophysiology and management of neuropathic and maladaptive pain–a report of the AMA Council on Science and Public Health. Pain Med. 2010;11(11):1635–1653. doi:10.1111/j.1526-4637.2010.00986.x21044254
   PubMed Web of Science ®Google Scholar